{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:31:41Z","timestamp":1790271101169,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>\u03b11-Antitrypsin deficiency is one of the most common heritable human diseases, predisposing to liver and lung injury. Significant heterogeneity in phenotypic expression is well documented, but less is known of the prevalence, severity, and correlates of chronic liver disease among individuals presenting with lung disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the frequency of and risk factors for severe liver fibrosis and cirrhosis among individuals with PiZZ-related lung disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A well-characterized cohort of 57 PiZZ adults attending a tertiary referral respiratory clinic was screened prospectively for clinical, laboratory, radiologic, and (when appropriate) histologic evidence of chronic liver disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Thirty-six (63.2%) of 57 had a history or clinical findings suggestive of liver disease; or had one or more abnormalities of liver function, or liver ultrasound, and 24 of these underwent liver biopsy. Ten (17.5%) had evidence of severe fibrosis or cirrhosis and were more likely to have higher body mass index (P = 0.04), alanine transaminase (P = 0.0001), alkaline phosphatase (P = 0.0009), prothrombin time (P = 0.0005), and maximal vital capacity (VCmax) (P = 0.04); lower platelet count (P = 0.007); abnormal liver echogenicity (P &amp;lt; 0.001); and splenomegaly (P = 0.001) at ultrasound. Screening with liver ultrasound provided a sensitivity and negative predictive value for severe fibrosis or cirrhosis of 100%, as were the specificity and positive predictive value for platelet count less than or equal to 174,000 per mm3 and splenomegaly. Among individuals undergoing liver biopsy, fibrosis stage correlated with increasing VCmax (P = 0.02) and % predicted VCmax (P = 0.05), and decreasing residual volume\/total lung capacity (TLC) (P = 0.02) and % predicted residual volume\/TLC (P = 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Significant chronic liver disease is common in PiZZ individuals with lung disease and can be screened effectively by a combination of conventional tests of liver function, platelet count, and liver ultrasound.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201204-0739oc","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T02:57:03Z","timestamp":1356145023000},"page":"502-508","source":"Crossref","is-referenced-by-count":52,"title":["Prevalence and Risk Factors for Liver Involvement in Individuals with PiZZ-related Lung Disease"],"prefix":"10.1093","volume":"187","author":[{"given":"Muhammad F.","family":"Dawwas","sequence":"first","affiliation":[{"name":"Liver Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J. H.","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Liver Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lomas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Liver Unit and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,3,1]]},"reference":[{"key":"2026032100530702800_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archinternmed.2009.25","article-title":"Myths and misconceptions about alpha-1-antitrypsin deficiency","volume":"169","author":"Stoller","year":"2009","journal-title":"Arch Intern Med"},{"key":"2026032100530702800_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1164\/rccm.201108-1428CI","article-title":"A review of alpha1-antitrypsin deficiency","volume":"185","author":"Stoller","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100530702800_bib3","first-page":"132","article-title":"The electrophoretic alpha 1-globulin pattern of serum in alpha 1-antitrypsin deficiency","volume":"15","author":"Laurell","year":"1963","journal-title":"Scand J Clin Lab Invest"},{"key":"2026032100530702800_bib4","first-page":"403","article-title":"Apha-1-1antitrypsin deficiency","author":"Lomas","year":"2010"},{"key":"2026032100530702800_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.biochem.78.082107.133320","article-title":"Conformational pathology of the serpins: themes, variations, and therapeutic strategies","volume":"78","author":"Gooptu","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"2026032100530702800_bib6","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.20072080","article-title":"Polymers and inflammation: disease mechanisms of the serpinopathies","volume":"205","author":"Gooptu","year":"2008","journal-title":"J Exp Med"},{"key":"2026032100530702800_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/thx.2003.006502","article-title":"Alpha1-antitrypsin deficiency. 2: Genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk","volume":"59","author":"DeMeo","year":"2004","journal-title":"Thorax"},{"key":"2026032100530702800_bib8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.21628","article-title":"Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review","volume":"45","author":"Perlmutter","year":"2007","journal-title":"Hepatology"},{"key":"2026032100530702800_bib9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM197606102942404","article-title":"Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants","volume":"294","author":"Sveger","year":"1976","journal-title":"N Engl J Med"},{"key":"2026032100530702800_bib10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1651-2227.1988.tb10767.x","article-title":"The natural history of liver disease in alpha 1-antitrypsin deficient children","volume":"77","author":"Sveger","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"2026032100530702800_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3109\/00365520903296669","article-title":"The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency","volume":"44","author":"Bernspang","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"2026032100530702800_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/ajrccm.158.1.9712017","article-title":"Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin","volume":"158","author":"The Alpha-1-Antitrypsin Deficiency Registry Study Group","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100530702800_bib13","first-page":"1196","article-title":"Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry","volume":"127","author":"Stoller","year":"2005","journal-title":"Chest"},{"key":"2026032100530702800_bib14","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.rmed.2009.04.004","article-title":"Mortality in alpha-1-antitrypsin deficiency in the UK","volume":"103","author":"Dawkins","year":"2009","journal-title":"Respir Med"},{"key":"2026032100530702800_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0954-6820.1978.tb08452.x","article-title":"Natural history and life expectancy in severe alpha1-antitrypsin deficiency (PiZZ)","volume":"204","author":"Larsson","year":"1978","journal-title":"Acta Med Scand"},{"key":"2026032100530702800_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1465-9921-11-44","article-title":"Survival in severe alpha-1-antitrypsin deficiency (PiZZ)","volume":"11","author":"Tanash","year":"2010","journal-title":"Respir Res"},{"key":"2026032100530702800_bib17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/thx.2008.095497","article-title":"Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ)","volume":"63","author":"Tanash","year":"2008","journal-title":"Thorax"},{"key":"2026032100530702800_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.0954-6820.1987.tb01281.x","article-title":"Alpha 1-antitrypsin deficiency and liver cirrhosis in adults: an analysis of 35 Swedish autopsied cases","volume":"221","author":"Eriksson","year":"1987","journal-title":"Acta Med Scand"},{"key":"2026032100530702800_bib19","first-page":"307","article-title":"Alpha-1-antitrypsin deficiency: natural course and therapeutic strategies","author":"Eriksson","year":"2001"},{"key":"2026032100530702800_bib20","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.humpath.2004.08.013","article-title":"The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the National Registry for individuals with Severe Deficiency of Alpha-1 Antitrypsin","volume":"35","author":"Tomashefski","year":"2004","journal-title":"Hum Pathol"},{"key":"2026032100530702800_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1542-3565(05)00082-0","article-title":"Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency","volume":"3","author":"Bowlus","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026032100530702800_bib22","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.cgh.2012.07.007","article-title":"Liver test results do not identify liver disease in adults with alpha(1)-antitrypsin deficiency","volume":"10","author":"Clark","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026032100530702800_bib23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114578","article-title":"Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy","volume":"85","author":"Crystal","year":"1990","journal-title":"J Clin Invest"},{"key":"2026032100530702800_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000201331","article-title":"Liver function in patients with pulmonary emphysema due to severe alpha-1-antitrypsin deficiency (Pi ZZ)","volume":"57","author":"von Sch\u00f6nfeld","year":"1996","journal-title":"Digestion"},{"key":"2026032100530702800_bib25","first-page":"151","article-title":"Alpha1-antitrypsin deficiency: current perspective on research, diagnosis, and management","volume":"1","author":"Stolk","year":"2006","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026032100530702800_bib26","first-page":"1353","article-title":"Liver transplantation: indications, preoperative evaluation and posttransplantation management","author":"Fink","year":"2009","edition":"1st ed"},{"key":"2026032100530702800_bib27","first-page":"930A","article-title":"Prevalence and risk factors for liver involvement in individuals with PiZ-related lung disease","volume":"54","author":"Dawwas","year":"2011","journal-title":"Hepatology"},{"key":"2026032100530702800_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"2026032100530702800_bib29","first-page":"165","article-title":"Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists","volume":"88","author":"Guidelines for the measurement of respiratory function","year":"1994","journal-title":"Respir Med"},{"key":"2026032100530702800_bib30","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary","volume":"163","author":"Pauwels","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100530702800_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1259\/bjr.72.853.10341686","article-title":"The diagnosis of cirrhosis by high resolution ultrasound of the liver surface","volume":"72","author":"Simonovsky","year":"1999","journal-title":"Br J Radiol"},{"key":"2026032100530702800_bib32","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/hep.20717","article-title":"Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C","volume":"41","author":"Lackner","year":"2005","journal-title":"Hepatology"},{"key":"2026032100530702800_bib33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2036.2005.02633.x","article-title":"Ultrasonographic and biochemical parameters in the non-invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis","volume":"22","author":"Iacobellis","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"2026032100530702800_bib34","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3748\/wjg.v12.i8.1292","article-title":"Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis","volume":"12","author":"Shen","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2026032100530702800_bib35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jhep.2009.12.031","article-title":"Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis","volume":"52","author":"Berzigotti","year":"2010","journal-title":"J Hepatol"},{"key":"2026032100530702800_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(83)90615-0","article-title":"Risk for liver disease in adults with alpha 1-antitrypsin deficiency","volume":"74","author":"Cox","year":"1983","journal-title":"Am J Med"},{"key":"2026032100530702800_bib37","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00042737-199610000-00010","article-title":"Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?","volume":"8","author":"Elzouki","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026032100530702800_bib38","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/00007890-199605270-00014","article-title":"Transplantation for end stage liver disease related to alpha 1 antitrypsin","volume":"61","author":"Vennarecci","year":"1996","journal-title":"Transplantation"},{"key":"2026032100530702800_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1378\/chest.110.1.78","article-title":"Alpha 1-antitrypsin deficiency deaths in the United States from 1979\u20131991. An analysis using multiple-cause mortality data","volume":"110","author":"Browne","year":"1996","journal-title":"Chest"},{"key":"2026032100530702800_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000088061","article-title":"Results of a survey of patients with alpha-1 antitrypsin deficiency","volume":"73","author":"Strange","year":"2006","journal-title":"Respiration"},{"key":"2026032100530702800_bib41","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1183\/09031936.00061208","article-title":"Rate of progression of lung function impairment in alpha1-antitrypsin deficiency","volume":"33","author":"Dawkins","year":"2009","journal-title":"Eur Respir J"},{"key":"2026032100530702800_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.mpg.0000226370.09085.39","article-title":"Variable degree of liver involvement in siblings with PiZZ alpha-1-antitrypsin deficiency-related liver disease","volume":"43","author":"Hinds","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2026032100530702800_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.21979","article-title":"A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease","volume":"47","author":"Chappell","year":"2008","journal-title":"Hepatology"},{"key":"2026032100530702800_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hep.22974","article-title":"Single nucleotide polymorphism-mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency","volume":"50","author":"Pan","year":"2009","journal-title":"Hepatology"},{"key":"2026032100530702800_bib45","author":"Talley"},{"key":"2026032100530702800_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cld.2007.02.007","article-title":"Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others","volume":"11","author":"Clouston","year":"2007","journal-title":"Clin Liver Dis"},{"key":"2026032100530702800_bib47","first-page":"1504","article-title":"Molecular pathogenesis of liver disease in alpha1-antitrypsin deficiency","volume":"24","author":"Teckman","year":"1996","journal-title":"Hepatology"},{"key":"2026032100530702800_bib48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2004.09.012","article-title":"The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies","volume":"42","author":"Adams","year":"2005","journal-title":"J Hepatol"},{"key":"2026032100530702800_bib49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","article-title":"Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis","volume":"51","author":"Argo","year":"2009","journal-title":"J Hepatol"},{"key":"2026032100530702800_bib50","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJM198603203141202","article-title":"Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency","volume":"314","author":"Eriksson","year":"1986","journal-title":"N Engl J Med"},{"key":"2026032100530702800_bib51","author":"Wilt"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/187\/5\/502\/67266592\/ajrccm_187_5_502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/187\/5\/502\/67266592\/ajrccm_187_5_502.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:53:53Z","timestamp":1774068833000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/187\/5\/502\/8510032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,3,1]]},"published-print":{"date-parts":[[2013,3,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201204-0739oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,3]]},"published":{"date-parts":[[2013,3,1]]}}}